FIRST TRIMESTER SCREEN

The First Trimester Screen is an at‑home maternal serum screening that measures pregnancy biomarkers (free β‑hCG and PAPP‑A) to provide an early risk assessment for common chromosomal abnormalities such as Down syndrome (Trisomy 21), Edwards (T18) and Patau (T13). Samples are collected discreetly at your Dubai residence by certified phlebotomists and analysed in accredited laboratories to deliver reliable risk scores, helping you and your clinician decide whether further non‑invasive prenatal testing (NIPT) or diagnostic testing is recommended. This service is suited for expectant mothers in the UAE seeking convenient, confidential early screening; results include professional lab reporting and should be reviewed with your obstetrician or genetic counsellor for appropriate follow‑up.

• Pregnancy-Associated Plasma Protein A (PAPP-A)
• Free Beta Human Chorionic Gonadotropin (free β-hCG)
• Nuchal Translucency (NT) measurement
• Crown–Rump Length (CRL)
• Nasal Bone assessment
• Calculated risk estimates for Trisomy 21, Trisomy 18 and Trisomy 13

• Blood-based first-trimester screening (PAPP‑A and free β‑hCG) to assess risk for trisomy 21, 18 and 13
• Convenient home sample collection by trained phlebotomists with discreet, UAE‑compliant handling
• Option to coordinate nuchal translucency ultrasound for combined screening where indicated
• Results from accredited UAE laboratories with secure digital risk report and clinician-recommended next steps
• Fast turnaround and flexible bookings timed for 11–13+6 weeks gestation

• Home blood draw for first‑trimester biochemical screening (PAPP‑A and free β‑hCG) with collection across Dubai
• Risk assessment for common chromosomal abnormalities (Trisomy 21, 18 and 13) — screening only, not diagnostic
• Processed by UAE‑accredited partner laboratories with certified, clinically validated reports
• Secure electronic results with clear risk interpretation, typically delivered within 48–72 hours
• Trained phlebotomist, discreet sample collection and optional follow‑up consultation to explain results

• At-home maternal blood draw by certified phlebotomist during the recommended 10–13+6 weeks of pregnancy
• Comprehensive risk assessment for common chromosomal abnormalities (trisomy 21, 18, 13) via accredited laboratory analysis
• Discreet sample collection with secure, UAE-compliant delivery of certified results to your portal within 48–72 hours
• Clear next-step guidance and referral for genetic counselling or confirmatory diagnostic testing in Dubai if the screen is high-risk